BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36685113)

  • 1. Evaluation of Lactate Dehydrogenase and Alkaline Phosphatase as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram.
    Su K; Huang W; Li X; Xu K; Gu T; Liu Y; Song J; Qian K; Xu Y; Zeng H; Yang Y; Guo L; Han Y
    J Hepatocell Carcinoma; 2023; 10():69-79. PubMed ID: 36685113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.
    Wu SJ; Lin YX; Ye H; Xiong XZ; Li FY; Cheng NS
    Int J Surg; 2016 Dec; 36(Pt A):143-151. PubMed ID: 27793641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel lactate dehydrogenase-based risk score model to predict the prognosis of primary central nervous system germ cell tumor treated with chemoradiotherapy.
    Yao DC; Ye BK; Yao DJ; Guo CC
    Clin Neurol Neurosurg; 2024 Jan; 236():108081. PubMed ID: 38091701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-treatment serum lactate dehydrogenase and alkaline phosphatase as predictors of metastases in extremity osteosarcoma.
    Marais LC; Bertie J; Rodseth R; Sartorius B; Ferreira N
    J Bone Oncol; 2015 Sep; 4(3):80-4. PubMed ID: 26587373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinoma.
    Wei XL; Zhang DS; He MM; Jin Y; Wang DS; Zhou YX; Bai L; Li ZZ; Luo HY; Wang FH; Xu RH
    Tumour Biol; 2016 Feb; 37(2):1879-87. PubMed ID: 26323257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study.
    Jiang Y; Guo L; Han L; Li H; Li C; Wen L; Song Y; Wang Z; Wang P; Guo Q; Zhao W; Liu M; Chen J; Wu Z; Yan Y; Xu K; Gu T; Wu X; He K; Su K; Han Y
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):14271-14282. PubMed ID: 37561208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-treatment serum alkaline phosphatase and lactate dehydrogenase as prognostic factors in triple negative breast cancer.
    Chen B; Dai D; Tang H; Chen X; Ai X; Huang X; Wei W; Xie X
    J Cancer; 2016; 7(15):2309-2316. PubMed ID: 27994669
    [No Abstract]   [Full Text] [Related]  

  • 8. Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis.
    Xu XS; Wan Y; Song SD; Chen W; Miao RC; Zhou YY; Zhang LQ; Qu K; Liu SN; Zhang YL; Dong YF; Liu C
    World J Gastroenterol; 2014 Aug; 20(31):10944-52. PubMed ID: 25152598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of ALP and LDH in Periampullary Carcinoma Patients Undergoing Surgery.
    Dang C; Deng YH; Qin RY
    Curr Med Sci; 2022 Feb; 42(1):150-158. PubMed ID: 34669114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of combined preoperative lactate dehydrogenase and alkaline phosphatase levels in patients with resectable pancreatic ductal adenocarcinoma.
    Ji F; Fu SJ; Guo ZY; Pang H; Ju WQ; Wang DP; Hua YP; He XS
    Medicine (Baltimore); 2016 Jul; 95(27):e4065. PubMed ID: 27399091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
    Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W
    Front Oncol; 2022; 12():946531. PubMed ID: 35936698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma.
    Wang X; Mao M; He Z; Zhang L; Li H; Lin J; He Y; Dai S; Hu W; Liu W
    Int J Biol Sci; 2019; 15(1):221-228. PubMed ID: 30662361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate dehydrogenase is a prognostic indicator in patients with hepatocellular carcinoma treated by sorafenib: results from the real life practice in HBV endemic area.
    Li MX; Zhao H; Bi XY; Li ZY; Yao XS; Li H; Huang Z; Han Y; Zhou JG; Zhao JJ; Zhang YF; Zhao DB; Cai JQ
    Oncotarget; 2016 Dec; 7(52):86630-86647. PubMed ID: 27880930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a nomogram combining hematological and imaging features for preoperative prediction of microvascular invasion in hepatocellular carcinoma patients.
    Zhou Q; Zhou C; Yin Y; Chen W; Liu C; Atyah M; Weng J; Shen Y; Yi Y; Ren N
    Ann Transl Med; 2021 Mar; 9(5):402. PubMed ID: 33842623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and validation of a clinical predictive nomogram for intraductal carcinoma of the prostate based on Chinese multicenter clinical data.
    Yang Y; Zhang W; Wan L; Tang Z; Zhang Q; Bai Y; Zhang D
    Front Oncol; 2022; 12():1074478. PubMed ID: 36591521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Nomogram for Sorafenib Benefit in Hepatitis B Virus-Related Hepatocellular Carcinoma After Partial Hepatectomy.
    Dong W; Yan K; Yu H; Huo L; Xian Z; Zhao Y; Li J; Zhang Y; Cao Z; Fu Y; Cong W; Dong H
    Front Oncol; 2020; 10():605057. PubMed ID: 33643907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic potential of alkaline phosphatase and lactic acid dehydrogenase in bmCRPC patients without significant PSA response under enzalutamide.
    Poteska R; Rahbar K; Semjonow A; Schrader AJ; Boegemann M; Schlack K
    BMC Cancer; 2022 Apr; 22(1):375. PubMed ID: 35395766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for disease-free survival in postoperative patients with hepatocellular carcinoma and construction of a nomogram model.
    Luo PQ; Ye ZH; Zhang LX; Song ED; Wei ZJ; Xu AM; Lu Z
    World J Clin Cases; 2022 Dec; 10(36):13250-13263. PubMed ID: 36683638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Nomogram Based on Circulating CD4
    Shen DS; Yan C; Chen KH; Li L; Qu S; Zhu XD
    J Inflamm Res; 2021; 14():6707-6718. PubMed ID: 34916820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.